SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?


To: TokyoMex who wrote (46408)1/24/1999 8:02:00 AM
From: ArtAlley  Respond to of 119973
 
ASCT buy-out question? Does anyone know the per share value of the two new drugs that will be coming out? It seems that preliminary approval has already been granted for these two drugs...but, what are they worth in a buy-out? How many millions(billions) per drug? We could be looking at a much more SPECTACULAR per share price increase than I had previously imagined! I am not trying to 'hype'...but, I can seriously see why this has taken some time...and might continue to take some more time. I did see $20 per share mentioned on another board even if there is no buy-out. This is getting interesting.

Here is an old posting from their website on the two drugs and the distinct possiblity of
approval. Nice website! Any CHEMISTRY majors out there?

Ascent Pediatrics Receives FDA Comments on Primsol NDA Application

Wilmington, MA - September 25, 1998 -- Ascent Pediatrics, Inc. (NASDAQ:
ASCT), today announced at the SG Cowen Healthcare Conference in San
Francisco, California that it received minor chemistry comments from the FDA on its
NDA application for its lead antibiotic product, Primsol(r). In the comment letter, the
FDA stated that it would accept a proposed new formulation of Primsol without
requiring Ascent to conduct additional clinical trials. Based on this comment letter,
Ascent believes that it will be able to obtain approval of its Primsol NDA application
from the FDA in mid-1999.

Dr. Emmett Clemente, Chairman and Founder of Ascent, stated, "We are very
encouraged by this comment letter from the FDA and expect to be able to achieve
mid-1999 approval of Primsol. We also believe that these comments provide useful
guidance to us in pursuing approval of our ANDA application for Orapred, our
second lead product, with the FDA."

Alan R. Fox, President and CEO of Ascent, also present at the SG Cowen
Healthcare Conference, stated, "In addition to Primsol and Orapred, we are also
pursuing co-promotional arrangements with third parties. Earlier this year we
concluded an important co-promotional agreement with Bristol-Myers Squibb for
Duricef Oral Suspension. Our strategy is to increase Ascent's revenues through
co-promotional agreements until our own products are approved by the FDA. We
expect to conclude at least one new agreement before the end of this year."

Ascent Pediatrics, Inc. is a drug development and marketing company focused
exclusively on the pediatric market. The Company's strategy is to address the unmet
needs of children through the development of differentiated, proprietary products
based on approved compounds with well known clinical profiles. Ascent is
developing a range of pharmaceuticals designed to improve upon currently available
products for common pediatric illness through the application of its delivery and
reformulation techniques.

------

Previous










To: TokyoMex who wrote (46408)1/24/1999 5:28:00 PM
From: Frost Byte  Read Replies (1) | Respond to of 119973
 
Two HUGE movers this week: BVSN & TMCS....you will want to buy these before the close on Monday.....also, I think you are being a little too bearish on the overall market.

Positives:

1) Internet stocks: Sharp reversal on Friday..despite everybody and their mother declaring these stocks a bubble...what does Barton Biggs know about the Internet? He probably has never used a computer.

2) China - China has absolutely no reason to devalue....in fact, devaluation would hurt their economy not help. They've got a $40bln trade surplus...read the article in the WSJ...no devaluation here.

3) Abby Joseph Cohen: Late on Friday she stated that she remained bullish on the market and said the Dow would hit 9850...this should hit CNBC, the press on Monday.

4) Clinton - On Monday they are voting to dismiss the charges...only 5 Republicans need to vote in favor and the whole impeachment thing is history.

5) Last Week - we already had a sharp sell-off last week and I believe we are short-term oversold.

6) Money continues to flow into equity mutual funds...simple supply/demand forces will prop market up.

7) Earnings have been sensational...especially tech earnings.

8) Brazil - yep, you got me on this one....but the financial markets are significantly deleveraged, the banks have been expecting this, and we've already been through this before with the Asian Crisis..

All in all, I expect an up week, especially for tech/Internet stocks....I'm telling ya, watch TMCS and BVSN on Monday and Tuesday.

-FB



To: TokyoMex who wrote (46408)1/24/1999 7:01:00 PM
From: JEB  Read Replies (1) | Respond to of 119973
 
Funny you should mention this. Do you remember last week when you got a strange feeling and checked the indexes?

So did I.

It was the same day because you put out the warning that night.

There is one nasty looking 'Flying M' pattern on the SPY (Spyder tr - S&P trade index). This is VERY BEARISH!

I am glad you posted that to everyone. We may see a sideways week. Most of the week but it won't last long unless there is some news that comes along to rally the market to a new high (I don't see anything yet).

It's best to be cash and get ready to short. We are day traders (Most of us). We can make money in both directions.

I'm eyeing some good shorts and I'll get back to you on them.

Put away the hats and noise makers. It's time to do some work.

Good trading,
JEB



To: TokyoMex who wrote (46408)1/24/1999 11:22:00 PM
From: RealMuLan  Read Replies (1) | Respond to of 119973
 
<<Well there are 240 such RITs in China !!! >>

Can you please tell me where do you get 240 figure. It sounds awfully high for me. Thanks.



To: TokyoMex who wrote (46408)1/25/1999 8:29:00 AM
From: tonto  Respond to of 119973
 
Tokyo, everyone should be focused on China. For the past couple of weeks I have advised that China very likely will be the largest financial concern that will shake our market this year. The debt load is staggering. Thanks for posting the article. I hope investors pay attention and never forget what is going on in China.

It is time for us to be dead serious with our money again ,, this year we might have a very late ground hog day ,,